FAST NEWS: MicroPort MedBot places shares at significant discount
The Latest: Shanghai MicroPort MedBot (Group) Co. Ltd. (2252.HK) on Thursday announced it placed 12.9 million new shares at a price of HK$9.10 per share, raising approximately HK$117 million ($15…
MedBot seeks commercial edge with dual-use surgical robot
The company’s orthopedic robot is the first domestically developed device to be approved for both hip and knee surgeries Key Takeaways: Even with its latest product, MicroPort MedBot faces intensifying…
Charged by Surgical Robot’s Approval, Shenzhen Edge Medical Makes New IPO Bid
The medical device maker filed a second time for a Hong Kong IPO after updating its prospectus with the recent approval of its first surgical robotKey Takeaways:Shenzhen Edge Medical got…
RELATED ARTICLES
-
MedBot seeks commercial edge with dual-use surgical robot
2252.HK
-
FAST NEWS: MicroPort MedBot vascular surgical robot approved in China
2252.HK
-
FAST NEWS: JPMorgan boosts MicroPort Scientific holdings
0853.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
- Reversing the Slide – Bamboo Works 2023 Year in Review Special Report
-
Caught in a payment jam, Hongjiu Fruit issues more shares
6689.HK
- Shanghai Refire hitches ride on Beijing’s green ambitions train as it eyes Hong Kong IPO
